Julie Yu Net Worth & Insider Trades
Julie Yu - VP Clinical Ops & Data Mgmt, Amicus Therapeutics Inc
What is Julie Yu's Net Worth?
The current estimated net worth of Amicus Therapeutics Inc's VP Clinical Ops & Data Mgmt, Julie Yu, is estimated to be about $745.21K . Julie Yu owns about 0 unit of Amicus Therapeutics Inc common stock. In the last year at Amicus Therapeutics Inc, Julie Yu has sold an estimated value of $438.46K worth.
What is Julie Yu's Past Insider Trading?
Julie Yu's largest purchase order was 7,785 units , worth over $89.59K on March 25, 2015. Julie Yu's largest sale order was 16,805 units , worth over $181.83K on May 12, 2015. In total, Julie Yu has made about 10 transactions over a year of their time at Amicus Therapeutics Inc. Julie Yu usually trades in June, with the busiest year in 2014 and 2015. The most recent transaction was a sale order of 8,195 units , worth over $116.12K on June 16, 2015.
Julie Yu
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Julie Yu's' Mailing Address?
- Mailing address is C/o Amicus Therapeutics, Inc. 1 Cedar Brook Drive Cranbury NJ 08512 NJ
Amicus Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Change in Pension Value
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John F. Crowley | 2020 | $719,514 | $514,800 | $5,479,971 | $2,492,491 | $1,282,843 | $825,505 | $11,315,124 |
| John F. Crowley | 2019 | $656,770 | $476,815 | $5,327,948 | $2,334,850 | $234,775 | $821,505 | $9,852,663 |
| John F. Crowley | 2018 | $637,640 | $445,710 | $3,861,699 | $1,654,347 | - | $820,567 | $7,419,963 |
| Daphne Quimi | 2020 | $45 | $228,712 | $1,534,382 | $697,894 | - | $34,639 | $2,947, |
| Daphne Quimi | 2019 | $400,000 | $212,960 | $1,311,492 | $538,808 | - | $17,487 | $2,480,747 |
| Daphne Quimi | 2018 | - | - | - | - | - | - | - |
| Bradley L. Campbell | 2020 | $515, | $368,872 | $2,557,304 | $1,163,159 | - | $33,694 | $4, |
| Bradley L. Campbell | 2019 | $500,877 | $378,788 | $2,254,114 | $987,822 | - | $19,538 | $4,141,139 |
| Bradley L. Campbell | 2018 | $468,109 | $327,209 | $1,411,802 | $604,817 | - | $16,710 | $2,828,646 |
| Hung Do | 2020 | $42 | $187,908 | $1,461,322 | $664,660 | - | $31,248 | $2,772,106 |
| Hung Do | 2019 | $414,625 | $200,678 | $1,393,462 | $574,732 | - | $22,129 | $2,605,626 |
| Hung Do | 2018 | - | - | - | - | - | - | - |
| Ellen S. Rosenberg | 2020 | $452, | $199,051 | $1,461,322 | $664,660 | $87,751 | $20,748 | $2,885,820 |
| Ellen S. Rosenberg | 2019 | $439,213 | $233,837 | $1,393,462 | $610,648 | - | $13,538 | $2,690,698 |
| Ellen S. Rosenberg | 2018 | $426,420 | $208,647 | $996,591 | $426,933 | - | $18,270 | $2,076,862 |
| Jay Barth | 2020 | $366,269 | - | $1,315,184 | $598,197 | - | $641,306 | $2,920,956 |
| Jay Barth | 2019 | $471,621 | $228,265 | $1,229,522 | $538,808 | - | $15,998 | $2,484,214 |
| Jay Barth | 2018 | $457,885 | $192,037 | $996,591 | $426,933 | - | $18,790 | $2,092,236 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1178879/000114036121014545/nc10021408x1_def14a.htm
What are Amicus Therapeutics Inc's Past Insider Trades?
Amicus Therapeutics Inc's most recent insider trade came on August 9, 2022 by Daphne Quimi who sold 5,798 units worth $69.58K . In the last 15 years, insiders at Amicus Therapeutics Inc have sold an estimated value of $174.83M and bought an estimated value of $192.08M worth of shares. Insider trading is most common in June, with the busiest year in 2008. The most active traders at the company are John Crowley, Executive Chairman, Bradley Campbell, President & CEO, and James N Topper, Director .
AMICUS THERAPEUTICS, INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||